Skip to main content

Table 8 In-vitro cytotoxicity of synthesized compounds against Breast cancer cell line (MCF-7) [51]

From: Therapeutic potential of oxadiazole or furadiazole containing compounds

Compound % Viability
6.25 μg/ml 12.5 μg/ml 25 μg/ml 50 μg/ml 100 μg/ml
11a 38.04 37.15 39.68 35.11 40.31
11b 38.26 42.70 37.90 38.84 43.24
11c 44.35 41.6 41.81 39.64 37.24
11d 42.70 39.46 40.48 37.61 37.37
11e 30.60 32.20 34.48 33.86 37.54
11f 32.57 33.09 30.88 30.75 24.87
11 g 34.39 33.58 28.80 32.40 30.96
11 h 32.03 35.40 31.25 33.69 34.45
  1. Control % viability = 100